Telix Pharmaceuticals acquires Swiss-German biotechnology company TheraPharm

This article was originally published here

The acquisition of TheraPharm provides Telix with access to a portfolio of patents, technologies, production systems, clinical data and know-how in relation to the use of Molecularly Targeted

The post Telix Pharmaceuticals acquires Swiss-German biotechnology company TheraPharm appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply